A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was 'In patients with resectable non-small-cell lung cancer, is video-assisted thoracoscopic segmentectomy a suitable alternative to thoracotomy and segmentectomy in terms of morbidity and equivalence of resection?' Altogether 232 papers were found as a result of the reported search, of which 7 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. Only one study compared the survival rates of video-assisted thoracoscopic surgery (VATS) and open surgery and found no significant difference in overall (P = 0.605) and disease-free (P = 0.996) survival between these groups. The mean length of hospital stay was reported as shorter following VATS when compared with open surgery in all of the studies looking at this outcome. The greatest difference in length of hospital stay reported was 4.8 days (VATS 3.5 days and open 8.3 days). The duration of chest tube placement was also universally reported as shorter in patients having VATS procedures when compared with open procedures. Two studies compared the number of lymph nodes that could be sampled when completing this operation by VATS using an open approach and neither found there to be a significant difference between these numbers. Using the evidence collected, we conclude that anatomical segmentectomy performed by VATS is a safe and effective alternative to conventional techniques in the surgical management of non-small-cell lung cancer. We are aware that the current evidence is limited and existing studies all examine small numbers of patients. Unfortunately, at present there is no blinded randomized control trial comparing these two surgical methods. There is also no study comparing the utility of each method for differing anatomical locations of segments. This should be kept in mind when interpreting the results of the studies presented.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] . 
THREE-PART QUESTION

CLINICAL SCENARIO
You are a cardiothoracic registrar attending a local multidisciplinary team meeting. The case of a 76-year old lady with a peripheral, 1.5-cm right upper lobe tumour (T1aN0M0) is presented.
In consideration of her coexisting chronic obstructive pulmonary disease, your consultant proposes sublobar resection using an open thoracotomy approach. You are aware of evidence supporting the use of video-assisted thoracoscopic surgery (VATS) segmentectomy in early non-small-cell lung cancer (NSCLC) and that this minimally invasive technique may reduce surgical morbidity. You discuss this with your consultant who explains that the oncological efficacy and feasibility of a VATS approach for sublobar resection requires further evaluation. He asks you to review the literature on this topic. OR NSCLC OR lung cancer). Finally, a manual search was used to follow up on references from the retrieved studies.
SEARCH OUTCOME
Two hundred and thirty-two papers were returned using the reported search. From these, six papers were identified that provided the best evidence to answer the question. Manual searches of the reference lists permitted the inclusion of one more article. These are presented in Table 1 .
RESULTS
Schuchert et al. Atkins et al. [4] retrospectively reviewed 77 patients who underwent thoracoscopic segmentectomy (n = 48) and open thoracotomy (n = 29). Within the thoracoscopic group, 27 patients were treated for primary lung cancer compared with 12 from the thoracotomy group. These NSCLC groups were similar regarding age, smoking history and pulmonary function; however, they differed in their preoperative staging in that 95% of the VATS group were Stage 1, while 25% of the thoracotomy group were Stage 2B/3A (16.7 Stage 2B and 8.3% Stage 3A). The incidence of loco-regional recurrence was similar (VATS 7.7 vs open 8.3%, P = 1.0). Hospital [5] conducted a retrospectively study of the feasibility of VATS segmentectomy in comparison with standard thoracotomy. The operative time was significantly longer for VATS cases; however, the perioperative and postoperative outcomes were otherwise equivalent. The length of hospital stay was significantly reduced for VATS patients ( 4 days). There was 100% recurrence-free survival in both cohorts; however, the follow-up period was relatively short.
BEST EVIDENCE TOPIC
Gossot et al. [6] demonstrated the efficacy of totally thoracoscopic anatomical segmentectomy in a group of 50 patients requiring sublobar resection. The cases included 25 clinically N0 NSCLC lesions, 16 benign and 9 metastatic lesions. The mean length of stay was 5.6 days (±2.4). Five patients experienced minor complications including mucous plugging (n = 2), air leak (n = 1), pneumothorax requiring chest drain insertion (n = 1) and 'neurological disorder' (n = 1). Witte et al. [7] performed an observational study demonstrating that VATS segmentectomy is a safe and efficacious procedure. The cases (n = 20) were proved or suspected Stage 1 lung cancer and all experienced an unremarkable postoperative course.
Watanabe et al. [8] studied 41 sublobar resection cases demonstrating the feasibility of VATS segmentectomy as a treatment for selected NSCLC patients. The cases included T1N0M0 peripheral NSCLC <2 cm (n = 38) and NSCLC with interlobar invasion (n = 3). The 5-year survival of the entire cohort and the Stage 1A group were reported as 74.5 (±9.3) and 89.9% (±7.1%), respectively. There were no cases of loco-regional recurrence; however, the authors report 4 cases of distant metastasis following VATS segmentectomy, brain (n = 2), lung (n = 1) and liver (n = 1).
CLINICAL BOTTOM LINE
We reviewed the available literature regarding VATS segmentectomy for Stage 1 NSCLC. A total of seven papers were chosen including four retrospective studies comparing VATS versus thoracotomy and three studies regarding the feasibility of VATS segmentectomy. Unfortunately, the anatomical locations of the segments removed were not available. For this reason, outcomes for VATS and open thoracotomy could not be examined by segment removed. The studies demonstrated that thoracoscopic segmentectomy is a feasible technique with at least equivalent levels of morbidity, recurrence and survival compared with open segmentectomy. Furthermore, several studies report significant differences in the length of hospital stay, postoperative complications and duration of chest tube placement, suggesting that in selected cases thoracoscopic segmentectomy may confer additional benefit to patients postoperatively compared with open segmentectomy.
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